Publication | Closed Access

A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)

MedicinePharmacologyColorectal CancerOral CiclosporinPharmacotherapyPharmacokinetic BiomodulationCancer TreatmentAdvanced Colorectal CancerOncologyRadiation OncologyCancer Research